Related Experiment Video

Updated: Oct 3, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

[Treatment of ischemic cardiopathy in the elderly: risk and benefits]

L Santangelo1, G Nigro, F Panico

  • 1Dipartimento di Scienze Cardio-Toraciche e Respiratorie Sezione di Cardiologia Seconda Università degli Studi Piazza L. Miraglia, 2 80138 Napoli.

Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology
|November 29, 2001
PubMed

Insights

The growing elderly population experiences more coronary heart disease. Managing heart conditions in older adults requires careful risk-benefit assessment for treatments like percutaneous coronary angioplasty.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Epidemiology

Context:

  • Societal demographic shifts show an increasing elderly population.
  • Coronary heart disease (CHD) prevalence rises with age.
  • Elderly patients often present with comorbidities complicating CHD management.

Purpose:

  • To highlight the epidemiological trends of CHD in the aging population.
  • To discuss the specific diagnostic and therapeutic challenges in elderly CHD patients.
  • To evaluate current treatment strategies for acute and chronic ischemic heart disease in the elderly.

Summary:

  • Epidemiological data reveal a demographic revolution, increasing the elderly population and, consequently, the incidence of coronary heart disease.
  • Acute coronary syndromes in the elderly are increasingly treated with percutaneous coronary angioplasty and thrombolytic agents, despite higher associated risks.
  • Chronic ischemic heart disease management in older adults necessitates a thorough risk-benefit analysis, even if therapeutic approaches are similar to younger patients.

Impact:

  • Informs clinical practice regarding the specific needs of elderly patients with heart disease.
  • Emphasizes the importance of individualized risk assessment for cardiovascular interventions in geriatrics.
  • Contributes to the understanding of age-related factors influencing cardiovascular disease outcomes and treatment efficacy.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...